Quick Takeaways
- RENAISSANCE TECHNOLOGIES LLC filed SCHEDULE 13G/A for Pacira BioSciences, Inc. Common Stock, par value $0.001 per share (PCRX).
- Disclosed ownership: 5%.
- Date of event: 01 Jul 2025.
RENAISSANCE TECHNOLOGIES LLC - 01 Jul 2025 SCHEDULE 13G/A Report for Pacira BioSciences, Inc. Common Stock, par value $0.001 per share (PCRX)
- Filing Manager
- RENAISSANCE TECHNOLOGIES LLC
- Reporting Manager
- Renaissance Technologies LLC
- Symbol
- PCRX
- Shares outstanding
- 42,935,763 shares
- Disclosed Ownership
- 2,138,201 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2025, 14:29:19 UTC
- Date of event
- 01 Jul 2025
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RENAISSANCE TECHNOLOGIES LLC disclosed 5% ownership in Pacira BioSciences, Inc. Common Stock, par value $0.001 per share (PCRX) on 01 Jul 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 13 Nov 2025, 14:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 5% | 2,138,201 | 2,138,201 | 0 | Brian Felczak | Chief Financial Officer | |
| Renaissance Technologies Holdings Corporation | 5% | 2,138,201 | 2,138,201 | 0 | Brian Felczak | Vice President |